litlas
Log inCreate account

Lars Lannfelt

Active 1992–2025

157
Papers
38,216
Citations
99
h-index
154
i10-index

Citations

Citations per year for Lars Lannfelt1991: 3 citations1992: 6 citations1993: 18 citations1994: 56 citations1995: 83 citations1996: 192 citations1997: 268 citations1998: 272 citations1999: 297 citations2000: 384 citations2001: 270 citations2002: 299 citations2003: 260 citations2004: 289 citations2005: 215 citations2006: 297 citations2007: 213 citations2008: 287 citations2009: 306 citations2010: 392 citations2011: 385 citations2012: 404 citations2013: 290 citations2014: 367 citations2015: 347 citations2016: 429 citations2017: 521 citations2018: 594 citations2019: 1,214 citations2020: 1,311 citations2021: 1,252 citations2022: 1,167 citations2023: 1,104 citations2024: 1,559 citations2025: 892 citations2026: 27 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 5,718 citing papers, 26.7% of this breakdownUnited Kingdom: 1,909 citing papers, 8.9% of this breakdownChina: 1,348 citing papers, 6.3% of this breakdownGermany: 1,264 citing papers, 5.9% of this breakdownSweden: 1,127 citing papers, 5.3% of this breakdownItaly: 808 citing papers, 3.8% of this breakdownCanada: 794 citing papers, 3.7% of this breakdownJapan: 667 citing papers, 3.1% of this breakdownAustralia: 664 citing papers, 3.1% of this breakdownFrance: 647 citing papers, 3% of this breakdownNetherlands: 611 citing papers, 2.8% of this breakdownSpain: 536 citing papers, 2.5% of this breakdown
0%26.7%Other 24.9%

Institutions

Fields

  • Medicine65.2%
  • Biochemistry, Genetics and Molecular Biology20.3%
  • Neuroscience9%
  • Nursing1.1%
  • Immunology and Microbiology0.9%
  • Computer Science0.7%
  • Other2.8%

Topics

  • Alzheimer's disease research and treatments19.9%
  • Dementia and Cognitive Impairment Research4.3%
  • Cholinesterase and Neurodegenerative Diseases4.3%
  • Computational Drug Discovery Methods3.6%
  • Neuroinflammation and Neurodegeneration Mechanisms3.5%
  • Prion Diseases and Protein Misfolding2.4%
  • Other62%

Coauthors

All papers

Open in search
  1. The Amyloid-β Pathway in Alzheimer’s Disease

    Authors: Harald Hampel, John Hardy, Kaj Blennow, Christopher Chen, George Perry, Seung Hyun Kim, Victor L. Villemagne, Paul Aisen, Michele Vendruscolo, Takeshi Iwatsubo, Colin L. Masters, Min Cho, Lars Lannfelt, Jeffrey L. Cummings, Andrea Vergallo - Molecular Psychiatry 2021 cited by 1,806

  2. A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer’s disease with lecanemab, an anti-Aβ protofibril antibody

    Authors: Chad J. Swanson, Yong Zhang, Shobha Dhadda, Jinping Wang, June Kaplow, Robert Lai, Lars Lannfelt, Heather Bradley, Martin Rabe, Akihiko Koyama, Larisa Reyderman, Donald A. Berry, Scott Berry, Robert J. Gordon, Lynn D. Kramer, Jeffrey L. Cummings - Alzheimer s Research & Therapy 2021 cited by 817

  3. Lecanemab, Aducanumab, and Gantenerumab — Binding Profiles to Different Forms of Amyloid-Beta Might Explain Efficacy and Side Effects in Clinical Trials for Alzheimer's Disease

    Authors: Linda Söderberg, Malin Johannesson, Patrik Nygren, Hanna Laudon, Fredrik Eriksson, Gunilla Osswald, Christer Möller, Lars Lannfelt - Neurotherapeutics 2022 cited by 413

  4. Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease

    Authors: Rebecca Sims, GERAD/PERADES, CHARGE, ADGC, EADI, Sven J. van der Lee, Adam C. Naj, Céline Bellenguez, Nandini Badarinarayan, Jóhanna Jakobsdóttir, Brian W. Kunkle, Anne Boland, Rachel Raybould, Joshua C Bis, Eden R. Martin, Benjamin Grenier‐Boley, Stefanie Heilmann‐Heimbach, Vincent Chouraki, Amanda Kuzma, Kristel Sleegers, Maria Vronskaya, Agustı́n Ruiz, Robert Graham, Robert Olaso, Per Hoffmann, Megan L. Grove, Badri N. Vardarajan, Mikko Hiltunen, Markus M. Nöthen, Charles C. White, Kara L. Hamilton‐Nelson, Jacques Epelbaum, Wolfgang Maier, Seung-Hoan Choi, Gary W. Beecham, Cécile Dulary, Stefan Herms, Albert V. Smith, Cory C. Funk, Céline Derbois, Andreas J. Forstner, Shahzad Ahmad, Hong‐Dong Li, Delphine Bacq, Denise Harold, Claudia L. Satizábal, Otto Valladares, Alessio Squassina, Rhodri Thomas, Jennifer A. Brody, Liming Qu, Pascual Sánchez‐Juan, Taniesha Morgan, Frank J. Wolters, Yi Zhao, Florentino Sánchez-García, Nicola Denning, Myriam Fornage, John Malamon, María Cándida Déniz Naranjo, Elisa Majounie, Thomas H. Mosley, Beth A. Dombroski, David Wallon, Michelle K. Lupton, Josée Dupuis, Patrice L. Whitehead, Laura Fratiglioni, Christopher Medway, Xueqiu Jian, Shubhabrata Mukherjee, Lina Keller, Kristelle Brown, Honghuang Lin, Laura B. Cantwell, Francesco Panza, Bernadette McGuinness, Sonia Moreno–Grau, Jeremy D. Burgess, Vincenzo Solfrizzi, Petra Proitsi, Hieab H.H. Adams, Mariet Allen, Davide Seripa, Pau Pástor, L. Adrienne Cupples, Nathan D. Price, Didier Hannequin, Ana Frank, Daniel Levy, Paramita Chakrabarty, Paolo Caffarra, Ina Giegling, Alexa Beiser, Vilmantas Giedraitis, Harald Hampel, Melissa E. Garcia, Xue Wang, Lars Lannfelt, Patrizia Mecocci, Gudny Eiriksdottir, Paul K. Crane, Florence Pasquier and 350 more - Nature Genetics 2017 cited by 1,104

  5. Alzheimer’s disease pathology propagation by exosomes containing toxic amyloid-beta oligomers

    Authors: Maitrayee Sinha, Anna Ansell-Schultz, Livia Civitelli, Camilla Hildesjö, Max Larsson, Lars Lannfelt, Martin Ingelsson, Martin Hallbeck - Acta Neuropathologica 2018 cited by 516

  6. Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17

    Authors: Mike Hutton, Corinne Lendon, Patrizia Rizzu, Matt Baker, Susanne Froelich, Henry Houlden, Stuart Pickering‐Brown, Sumi Chakraverty, Adrian M. Isaacs, Andrew Grover, Jennifer Hackett, Jennifer Adamson, Sarah Lincoln, Dennis W. Dickson, Peter J. Davies, Ronald C. Petersen, Martijn Stevens, Esther de Graaff, Erwin Wauters, Jeltje van Baren, Marcel Hillebrand, Marijke Joosse, Jennifer M. Kwon, Petra Nowotny, Lien Kuei, Joanne Norton, John C. Morris, Lee Reed, John Q. Trojanowski, Hans Basun, Lars Lannfelt, Michael Neystat, Stanley Fahn, Francis Dark, Tony Tannenberg, Peter R. Dodd, Nick Hayward, John B. Kwok, Peter R. Schofield, Athena Andreadis, Julie S. Snowden, David Craufurd, David Neary, F. Owen, Ben A. Oostra, John Hardy, Alison Goate, John C. van Swieten, David Mann, Timothy Lynch, Peter Heutink - Nature 1998 cited by 3,540

  7. Mosaic loss of chromosome Y in peripheral blood is associated with shorter survival and higher risk of cancer

    Authors: Lars A. Forsberg, Chiara Rasi, Niklas Malmqvist, Hanna Davies, Saichand Pasupulati, Geeta Pakalapati, Johanna Sandgren, Teresita Díaz de Ståhl, Ammar Zaghlool, Vilmantas Giedraitis, Lars Lannfelt, Joannah Score, Nicholas C.P. Cross, Devin Absher, Eva Tiensuu Janson, Cecilia M. Lindgren, Andrew P. Morris, Erik Ingelsson, Lars Lind, Jan P. Dumanski - Nature Genetics 2014 cited by 459

  8. The 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enhanced Aβ protofibril formation

    Authors: Camilla Nilsberth, Anita Westlind‐Danielsson, Christopher B. Eckman, Margaret M. Condron, Karin Axelman, Charlotte Forsell, Charlotte Stenh, Johan Luthman, David B. Teplow, Steven G. Younkin, Jan Näslund, Lars Lannfelt - Nature Neuroscience 2001 cited by 1,206

  9. The Murine Version of BAN2401 (mAb158) Selectively Reduces Amyloid-β Protofibrils in Brain and Cerebrospinal Fluid of tg-ArcSwe Mice

    Authors: Stina Tucker, Christer Möller, Karin Tegerstedt, Anna Lord, Hanna Laudon, Johan Sjödahl, Linda Söderberg, Erika Spens, Charlotte Sahlin, Erik Rollman Waara, Andrew Satlin, Pär Gellerfors, Gunilla Osswald, Lars Lannfelt - Journal of Alzheimer s Disease 2014 cited by 272

  10. Safety and tolerability of BAN2401 - a clinical study in Alzheimer’s disease with a protofibril selective Aβ antibody

    Authors: Veronika Logovinsky, Andrew Satlin, Robert Lai, Chad J. Swanson, June Kaplow, Gunilla Osswald, Hans Basun, Lars Lannfelt - Alzheimer s Research & Therapy 2016 cited by 283

  11. Secreted amyloid β–protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease

    Authors: Donalyn Scheuner, Christopher B. Eckman, M. Jensen, X.H. Song, Martin Citron, Nobuhiro Suzuki, Thomas D. Bird, John Hardy, M. Hutton, Walter A. Kukull, Eric B. Larson, Ephrat Levy‐Lahad, Matti Viitanen, Elaine R. Peskind, Parvoneh Poorkaj, Gerald D. Schellenberg, Rudolph E. Tanzi, Wilma Wasco, Lars Lannfelt, Dennis J. Selkoe, Samuel Younkin - Nature Medicine 1996 cited by 2,604

  12. A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N–terminus of β–amyloid

    Authors: Mike Mullan, Fiona Crawford, Karin Axelman, Henry Houlden, Lena Lilius, Bengt Winblad, Lars Lannfelt - Nature Genetics 1992 cited by 1,505

  13. Mosaic Loss of Chromosome Y in Blood Is Associated with Alzheimer Disease

    Authors: Jan P. Dumanski, Jean‐Charles Lambert, Chiara Rasi, Vilmantas Giedraitis, Hanna Davies, Benjamin Grenier‐Boley, Cecilia M. Lindgren, Dominique Campion, Carole Dufouil, Florence Pasquier, Philippe Amouyel, Lars Lannfelt, Martin Ingelsson, Lena Kilander, Lars Lind, Lars A. Forsberg - The American Journal of Human Genetics 2016 cited by 263

  14. Bivalent Brain Shuttle Increases Antibody Uptake by Monovalent Binding to the Transferrin Receptor

    Authors: Greta Hultqvist, Stina Syvänen, Xiaotian T. Fang, Lars Lannfelt, Dag Sehlin - Theranostics 2016 cited by 236

  15. Sensitive ELISA detection of amyloid‐β protofibrils in biological samples

    Authors: Hillevi Englund, Dag Sehlin, Ann‐Sofi Johansson, Lars Nilsson, Pär Gellerfors, Staffan Paulie, Lars Lannfelt, Frida Ekholm Pettersson - Journal of Neurochemistry 2007 cited by 304

  16. Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene

    Authors: Е. И. Рогаев, Robin Sherrington, Ekaterina Rogaeva, Georges Lévesque, Masaki Ikeda, Yuh‐Jin Liang, Hongbo Chi, Chen-Xi Lin, K. Holman, T. Tsuda, Lynn Mar, Sandro Sorbi, Benedetta Nacmias, Silvia Piacentini, L. Amaducci, Ilya Chumakov, Daniel Cohen, Lars Lannfelt, Paul E. Fraser, Johanna M. Rommens, Peter St George‐Hyslop - Nature 1995 cited by 2,067

  17. Safety, efficacy, and biomarker findings of PBT2 in targeting Aβ as a modifying therapy for Alzheimer's disease: a phase IIa, double-blind, randomised, placebo-controlled trial

    Authors: Lars Lannfelt, Kaj Blennow, Henrik Zetterberg, Stellan Båtsman, David Ames, John Harrison, Colin L. Masters, Steve Targum, Ashley I. Bush, Ross Murdoch, Janet Wilson, Craig Ritchie - The Lancet Neurology 2008 cited by 712

  18. Large-scale analyses of common and rare variants identify 12 new loci associated with atrial fibrillation

    Authors: Ingrid E. Christophersen, Michiel Rienstra, Carolina Roselli, Xiaoyan Yin, Bastiaan Geelhoed, John Barnard, Honghuang Lin, Dan E. Arking, Albert V. Smith, Christine M. Albert, Mark Chaffin, Nathan R. Tucker, Molong Li, Derek Klarin, Nathan A. Bihlmeyer, Siew‐Kee Low, Peter Weeke, Martina Müller‐Nurasyid, J. G. Smith, Jennifer A. Brody, Maartje N. Niemeijer, Marcus Dörr, Stella Trompet, Jennifer E. Huffman, Stefan Gustafsson, Claudia Schurmann, Marcus E. Kleber, Leo‐Pekka Lyytikäinen, Ilkka Seppälä, Rainer Malik, Andréa R. V. R. Horimoto, Marco Pérez, Juha Sinisalo, Stefanie Aeschbacher, Sébastien Thériault, Jie Yao, Farid Radmanesh, Stefan Weiß, Alexander Teumer, Seung Hoan Choi, Lu‐Chen Weng, Sebastian Clauß, Rajat Deo, Daniel J. Rader, Svati H. Shah, Albert Y. Sun, Jemma C. Hopewell, Stéphanie Debette, Ganesh Chauhan, Qiong Yang, Bradford B. Worrall, Guillaume Paré, Yoichiro Kamatani, Yanick Hagemeijer, Niek Verweij, Joylene E. Siland, Michiaki Kubo, Jonathan D. Smith, David R. Van Wagoner, Joshua C Bis, Siegfried Perz, Bruce M. Psaty, Paul M. Ridker, Jared W. Magnani, Tamara B. Harris, Lenore J. Launer, M. Benjamin Shoemaker, Sandosh Padmanabhan, Jeffrey Haessler, Traci M. Bartz, Mélanie Waldenberger, Peter Lichtner, Marina Arendt, José Eduardo Krieger, Mika Kähönen, Lorenz Risch, Alfredo José Mansur, Annette Peters, Blair H. Smith, Lars Lind, Stuart A. Scott, Yingchang Lu, Erwin B. Bottinger, Jussi Hernesniemi, Cecilia M. Lindgren, Jorge Wong, Jie Huang, Markku Eskola, Andrew P. Morris, Ian Ford, Alex P. Reiner, Graciela Delgado, Lin Y. Chen, Yii-Der Ida Chen, Roopinder K. Sandhu, Man Li, Eric Boerwinkle, Lewin Eisele, Lars Lannfelt, Natalia S. Rost and 62 more - Nature Genetics 2017 cited by 357

  19. CRISPR/Cas9 Mediated Disruption of the Swedish APP Allele as a Therapeutic Approach for Early-Onset Alzheimer’s Disease

    Authors: Bence György, Camilla Lööv, Mikołaj Piotr Zaborowski, Shuko Takeda, Benjamin P. Kleinstiver, Caitlin Commins, Ksenia V. Kastanenka, Dakai Mu, Adrienn Volak, Vilmantas Giedraitis, Lars Lannfelt, Casey A. Maguire, J. Keith Joung, Bradley T. Hyman, Xandra O. Breakefield, Martin Ingelsson - Molecular Therapy — Nucleic Acids 2018 cited by 189

  20. Cerebrospinal fluid levels of the synaptic protein neurogranin correlates with cognitive decline in prodromal Alzheimer's disease

    Authors: Hlin Kvartsberg, Flora H. Duits, Martin Ingelsson, Niels Andreasen, Annika Öhrfelt, Kerstin Andersson, Gunnar Brinkmalm, Lars Lannfelt, Lennart Minthon, Oskar Hansson, Ulf Andréasson, Charlotte E. Teunissen, Philip Scheltens, Wiesje M. van der Flier, Henrik Zetterberg, Erik Portelius, Kaj Blennow - Alzheimer s & Dementia 2014 cited by 365

  21. Smoking is associated with mosaic loss of chromosome Y

    Authors: Jan P. Dumanski, Chiara Rasi, Mikael Lönn, Hanna Davies, Martin Ingelsson, Vilmantas Giedraitis, Lars Lannfelt, Patrik K. E. Magnusson, Cecilia M. Lindgren, Andrew P. Morris, David Cesarini, Magnus Johannesson, Eva Tiensuu Janson, Lars Lind, Nancy L. Pedersen, Erik Ingelsson, Lars A. Forsberg - Science 2014 cited by 236

  22. PBT2 Rapidly Improves Cognition in Alzheimer's Disease: Additional Phase II Analyses

    Authors: Noel G. Faux, Craig Ritchie, Adam P. Gunn, Alan Rembach, Andrew Tsatsanis, Justin Bedő, John Harrison, Lars Lannfelt, Kaj Blennow, Henrik Zetterberg, Martin Ingelsson, Colin L. Masters, Rudolph E. Tanzi, Jeffrey L. Cummings, Caroline M. Herd, Ashley I. Bush - Journal of Alzheimer s Disease 2010 cited by 395

  23. Accumulation of amyloid-β by astrocytes result in enlarged endosomes and microvesicle-induced apoptosis of neurons

    Authors: Sofia Söllvander, Elisabeth Nikitidou, Robin Brolin, Linda Söderberg, Dag Sehlin, Lars Lannfelt, Anna Erlandsson - Molecular Neurodegeneration 2016 cited by 266

  24. Loss of Astrocyte Polarization in the Tg-ArcSwe Mouse Model of Alzheimer's Disease

    Authors: Jing Yang, Lisa K. Lunde, Paworn Nuntagij, Tomohiro Oguchi, Laura M. A. Camassa, Lars Nilsson, Lars Lannfelt, Yuming Xu, Mahmood Amiry‐Moghaddam, Ole Petter Ottersen, Reidun Torp - Journal of Alzheimer s Disease 2011 cited by 233